Viewing Study NCT06490380



Ignite Creation Date: 2024-07-17 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06490380
Status: COMPLETED
Last Update Posted: 2024-07-08
First Post: 2024-06-30

Brief Title: HRD Status Reference Standard Based on WGS
Sponsor: Lei Li
Organization: Peking Union Medical College Hospital

Study Overview

Official Title: A Collaborative Project Aimed to Establish a WGS-based Reference Standard for Evaluating the Analytical Performance of HRD Status Testing
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: When evaluating the analytical performance of homologous recombination deficiency HRD status testing there is currently no widely accepted reference standard Therefore a collaborative project was initiated to establish a HRD status reference standard for the industry Although there is no genotyping strategy that is universally recognized as the most accurate for evaluating HRD status whole-genome sequencing WGS is one of the best candidates
Detailed Description: Primary objective To establish a HRD status reference standard based on WGS
Secondary objective To validate the analytical performance of panel HRD status using WGS HRD status as reference standard
Exploratory objective 1 To explore how methylation of selective genes correlate with WGS HRD status and efficacy
Exploratory objective 2 To explore how HRR gene mutations correlate with WGS HRD status and efficacy
Exploratory objective 3 To set up a harmonized bioinformatic analysis workflow for WGS HRD status

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None